Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Aug 19, 2020 08:31AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
BMO have it still at .oo13 cents as that was last trade on July 27th.